We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
Cap. Flow
-$248M
Cap. Flow %
-0.63%
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148

Sector Composition

Rank Sector Weight
1 Technology 11.27%
2 Financials 10.78%
3 Industrials 9.91%
4 Healthcare 9.19%
5 Consumer Staples 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRC icon
551
NRC Health Common Stock
NRC
$474M
$4.34M 0.01%
65,751
+1,688
+3% +$103K
AZN icon
552
AstraZeneca
AZN
$263B
$4.33M 0.01%
43,387
-269
-0.6% -$25.3K
PFG icon
553
Principal Financial Group
PFG
$23.6B
$4.32M 0.01%
78,463
-136
-0.2% -$7.44K
VGT icon
554
Vanguard Information Technology ETF
VGT
$139B
$4.31M 0.01%
140,920
+13,432
+11% +$384K
IGLB icon
555
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.59B
$4.3M 0.01%
64,575
+8,260
+15% +$548K
MCO icon
556
Moody's
MCO
$81.7B
$4.3M 0.01%
18,116
+315
+2% +$70K
CRTO icon
557
Criteo
CRTO
$1.03B
$4.29M 0.01%
247,509
+23,803
+11% +$424K
PRFZ icon
558
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.75B
$4.29M 0.01%
156,850
+5,955
+4% +$157K
GNRC icon
559
Generac Holdings
GNRC
$11.9B
$4.29M 0.01%
42,617
-8,031
-16% -$748K
LMBS icon
560
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.32B
$4.28M 0.01%
82,585
+6,819
+9% +$354K
CHL
561
DELISTED
China Mobile Limited
CHL
$4.26M 0.01%
100,885
+1,368
+1% +$55.2K
WST icon
562
West Pharmaceutical
WST
$23.1B
$4.23M 0.01%
28,140
+1,017
+4% +$148K
FEX icon
563
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.58B
$4.22M 0.01%
64,661
+406
+0.6% +$25.4K
RPM icon
564
RPM International
RPM
$13.7B
$4.15M 0.01%
54,058
+682
+1% +$49.5K
AVY icon
565
Avery Dennison
AVY
$12.3B
$4.13M 0.01%
31,607
-4,500
-12% -$568K
INFO
566
DELISTED
IHS Markit Ltd. Common Shares
INFO
$4.13M 0.01%
54,838
-1,313
-2% -$93.4K
YUMC icon
567
Yum China
YUMC
$14.9B
$4.12M 0.01%
85,872
+11,695
+16% +$520K
ATVI
568
DELISTED
Activision Blizzard
ATVI
$4.12M 0.01%
69,395
-3,602
-5% -$199K
MKL icon
569
Markel Group
MKL
$25B
$4.1M 0.01%
3,590
+70
+2% +$79.7K
XYL icon
570
Xylem
XYL
$28.5B
$4.09M 0.01%
51,881
-5,214
-9% -$406K
IDXX icon
571
Idexx Laboratories
IDXX
$42.9B
$4.08M 0.01%
15,640
+1,214
+8% +$320K
KSU
572
DELISTED
Kansas City Southern
KSU
$4.07M 0.01%
26,542
+495
+2% +$72.6K
SONY icon
573
Sony
SONY
$123B
$4.02M 0.01%
295,690
+64,770
+28% +$808K
HSIC icon
574
Henry Schein
HSIC
$9.74B
$4.02M 0.01%
60,210
+217
+0.4% +$14.4K
PNW icon
575
Pinnacle West Capital
PNW
$12.9B
$3.99M 0.01%
44,324
-1,965
-4% -$177K

Similar funds

US Bancorp's Q4 2019 Portfolio in Review

As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
  • US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
  • US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
  • US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
  • US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
  • US Bancorp opened 218 new positions and closed 148 in Q4 2019.
  • US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.

Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.